Background/Purpose: We evaluated the long-term effects of green tea extract (GTE) supplementation on oxidative stress, biliary acute phase protein expression, and liver function in CCl 4 -induced chronic liver injury. Methods: We evaluated the antioxidant activity of GTE in comparison with those of vitamin C, vitamin E, and b-carotene in vitro by using an ultrasensitive chemiluminescence analyzer. Chronic liver injury was induced by intraperitoneally administering carbon tetrachloride (CCl 4 ) (1 mL/kg body weight, twice weekly) to female Wistar rats for 8 weeks. The effects of low (4 mg/kg body weight per day) and high (20 mg/kg body weight per day) doses of intragastric GTE on CCl 4 -induced liver dysfunction and fibrosis were examined by measuring the bile and blood reactive oxygen species levels and biochemical parameters by using Western blot and two-dimensional polyacrylamide gel electrophoresis techniques. Results: GTE has greater scavenging activity against O 2 e , H 2 O 2 , and Hypochlorous acid (HOCl) in vitro than vitamin C, vitamin E, and b-carotene do. In vivo, CCl 4 markedly increased bile and blood reactive oxygen species production, lipid accumulation, number of infiltrated leukocytes, fibrosis, hepatic hydroxyproline content, and plasma alanine aminotransferase and aspartate aminotransferase activities, and reduced plasma albumin levels. Two-dimensional polyacrylamide gel electrophoresis revealed that CCl 4 increased the acute-phase expression of six biliary proteins and decreased hepatic B-cell lymphoma 2 (Bcl-2), catalase, and CuZn superoxide dismutase protein expression. GTE supplementation attenuated CCl 4 -enhanced oxidative stress, levels of biochemical parameters, pathology, and acute-phase protein secretion, and preserved antioxidant/antiapoptotic protein expression. Conclusion: GTE supplementation attenuates CCl 4 -induced hepatic oxidative stress, fibrosis, acute phase protein excretion, and hepatic dysfunction via the antioxidant and antiapoptotic defense mechanisms.
Introduction
Hepatocellular apoptosis, hepatic inflammation, and fibrosis are prominent features of chronic liver disease. 1 Experimental and clinical data from several studies have suggested that oxidative stress plays a critical role in chronic liver damage and hepatic fibrosis. 2 Carbon tetrachloride (CCl 4 ) is a widely used industrial solvent, and it is the best-characterized animal model of xenobiotic-induced, oxidative stress-mediated hepatotoxicity. 3 The symptoms of CCl 4 -induced chronic liver injury are similar to those of chronic liver injury in humans. 4 CCl 4 induces the production of several types of reactive oxygen species (ROS) via cytochrome P450, thereby causing liver injury. 5 These ROS can bind to polyunsaturated fatty acids, forming alkoxy and peroxyl radicals to produce lipid peroxide, cause cell membrane damage, cause changes in enzyme activity, 6 and consequently induce hepatic injury, inflammation, apoptosis, and necrosis. 7, 8 Since antioxidants have antiviral, anti-inflammatory, antifibrogenic, and anticarcinogenic potential, their use has been proposed as an adjunctive therapy for various liver diseases. Antioxidants such as green tea extracts (GTE) containing (þ)-catechin (C), (e)-epicatechin, (þ)-gallocatechin, (e)-epigallocatechin, (e)-epicatechin gallate, and (e)-epigallocatechin gallate (EGCG) are popular and are recognized to exert protective effects against bladder hyperactivity, 9 cancer, 10 lipogenesis, 11 inflammation, 10, 12 atherosclerosis, 12 and acute liver injury. 8 GTE inhibited inflammation and apoptosis through decrease in ROS production, translocation of nuclear factor-kB and activated protein-1, and expression of intercellular adhesion molecule-1.
7,9 GTE showed dose-dependent, palliative effects against hemodialysis-enhanced plasma H 2 O 2 and Hypochlorous acid (HOCl) activities, lipid peroxide (phosphatidylcholine hydroperoxide) production, and C-reactive protein and proinflammatory cytokine expression in endstage renal disease patients. 12 Furthermore, GTE is more effective in scavenging plasma H 2 O 2 and HOCl activity compared to vitamins C and E. 13 Data have suggested that GTE administration prevents the development of hepatic fibrosis in rats with dimethylnitrosamine or CCl 4 -induced 14 liver injury 15 and inhibits the number of glutathione S-transferase placental form-and gamma-glutamyl transpeptidase-positive hepatic foci and areas in aflatoxin B1-initiated and CCl 4 -promoted hepatocarcinogenesis. 16 EGCG, the primary active component of GTE, exhibited anti-inflammatory, antioxidant, and immunosuppressive effects, improved liver dysfunction, reduced liver inflammatory infiltration and hepatocyte apoptosis, and abrogated tumor necrosis factor-alpha and interferon-gamma expression at the protein level in plasma. 17 EGCG also attenuated hepatic hydroxyproline content and hepatic stellate cell activation, as well as matrix metalloproteinase-2 activity and protein expression. 18 Proteomic analysis of bile fluid holds promise as a technique for the identification of biomarkers in various kinds of liver diseases. Our previous studies found that altered biliary secretion profiles of several acute-phase proteins directly indicate oxidative stress affecting intracellular trafficking in hepatocytes. 8 GTE supplementation reduced hepatotoxicity-induced oxidative stress and liver dysfunction and normalized the alteration of several acute-phase protein expressions. The differentially displayed proteomes suggested the potential application of proteomic analysis for bile fluid analysis.
In this study, we performed proteomic analysis of bile fluid by using two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) techniques to identify disease-associated biomarkers in the control, CCl 4 -treated, and CCl 4 plus GTEtreated groups. We also evaluated the effects of chronic GTE supplementation on CCl 4 -induced oxidative injury, inflammation, and fibrosis in rats. Our data showed that safe dosage of GTE protects the liver against CCl 4 injury via antioxidative, anti-inflammatory, antiapoptotic, and antifibrotic processes.
Materials and methods

Animals
Twenty-four female Wistar rats (weight, 220e255 g) were purchased and housed at the Experimental Animal Center, National Taiwan University, at a constant temperature and with a consistent light cycle (light from 7:00 AM to 6:00 PM). Food and water were provided ad libitum. All surgical and experimental procedures were approved by the Institutional Animal Care and Use Committee of National Taiwan University College of Medicine and College of Public Health and were in accordance with the guidelines of the National Science Council of the Republic of China (NSC, 1997).
To induce chronic liver injury, we injected CCl 4 (Showa Chemical Co., Ltd., Tokyo, Japan) intraperitoneally for 8 weeks. We divided the animals into the following four groups (n Z 6 each): control group, in which olive oil was intraperitoneally administered at a dose of 1 mL/kg body weight; CCl 4 treatment group, in which CCl 4 solution was intraperitoneally administered (CCl 4 in olive oil in a ratio of 1:1; dose, 1 mL/kg body weight, twice weekly); CCl 4 plus high-dose GTE (HGT) treatment group, in which CCl 4 solution was intraperitoneally administered and GTE was intragastrically administered (20 mg/kg body weight per day); and CCl 4 plus low-dose GTE (LGT) treatment group, in which CCl 4 solution was intraperitoneally administered and GTE was intragastrically administered (4 mg/kg body weight per day). Decaffeinated GTE catechins containing 328 mg/g of EGCG, 152 mg/g of (e)-epicatechin gallate, 148 mg/g of gallocatechin gallate, 132 mg/g of (e)-epicatechin, 108 mg/g of (e)-epigallocatechin, 104 mg/g of (þ)-gallocatechin, and 44 mg/g of C were purchased from Numen Biotech Co., Ltd. (Taipei, Taiwan).
On the day of the experiment, the animals were anesthetized by subcutaneously administering 1.2 g/kg urethane (Sigma, St. Louis, MO, USA). Their arterial blood pressure and bile flow were measured. 8 At the end of each experiment, the animals were sacrificed by overdose of anesthetics. Bile, plasma, and liver were stored at e70 C until analysis.
In vivo chemiluminescence recording of ROS activity
The ROS generation in response to 8 weeks of CCl 4 -induced liver injury was measured in bile and whole blood samples via a modified chemiluminescence detection method as described previously. 7, 8 In brief, 0.2 mL of blood or bile samples were mixed with 0.5 mL of 0.1 mmol/L lucigenin or 0.2 mmol/L luminal, and were analyzed using a Chemiluminescence Analyzing System (CLD-110, Tohoku Electronic Inc. Co., Sendai, Japan). Each assay was performed in triplicate and was expressed as the chemiluminescence count per 10 seconds.
To compare the antioxidant potentials of catechins, vitamin C, vitamin E, and b-carotene, we evaluated their inhibitory effects on O 2 e. , H 2 O 2 , and HOCl activity in vitro. We evaluated 0.2 mL of each test sample for O 2 e activity induced by 0.1 mL xanthine (final concentration, 100 mM) plus 0.1 mL xanthine oxidase (final concentration, 2.5 mU/mL) in 0.5 mL of 0.1 mmol/L lucigenin solution. We also evaluated 0.2 mL of the test sample on 0.1 mL of 0.003%
, H 2 O 2 , and HOCl activities were detected using a Chemiluminescence Analyzing System (CLD-110, Tohoku Electronic Inc. Co.).
Biochemical analysis
The plasma alanine aminotransferase (ALT) and aspartate aminotransferase levels were assayed using commercial kits (Sigma-Aldrich, St. Louis, MO, USA). The concentration of plasma albumin was measured using a clinical chemistry analyzer (Fuji Dri-Chem 4000, Tokyo, Japan). Hydroxyproline content was measured as described previously. 19 Biliary transferrin and haptoglobin concentrations were measured using the Rat Transferrin ELISA Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan) and Rat Haptoglobin ELISA Kit (Wako Pure Chemical Industries), respectively.
Two-dimensional electrophoresis
Bile is secreted by hepatocytes; therefore, proteomic profiles of bile may provide specific information and protein markers of the hepatic responses to CCl 4 -induced injury and GTE effects. The collected bile was analyzed via two-dimensional electrophoresis (2-DE) gel techniques as described previously. 8 
Peptide analysis via mass spectrometry
The method of analysis has been reported in detail elsewhere. 8 Matrix-assisted laser desorption/ionization (MALDI) time-of-flight mass spectrometry (MALDI-TOF MS) analysis was conducted using a Voyager DE-STR workstation (PerSeptive Biosystems, Framingham, MA, USA) equipped with a 337-nm nitrogen laser. The peptide mass fingerprint data were compared to those in the NCBInr protein database using the Mascot searching tool (http://www. matrixscience.com). The following search parameters were included: Database, NCBInr; taxonomy, Homo sapiens; enzyme, trypsin; peptide charge, 1þ; instrument, MALDI-QUAD-TOF.
Western blot analysis
We measured the expression of transferrin, haptoglobin, Bcell lymphoma 2 (Bcl-2), catalase, and CuZn superoxide dismutase (SOD) in the total protein content from the liver samples. Protein concentration was determined using a BioRad Protein Assay (Bio-Rad Laboratories, Hercules, CA, USA). Ten micrograms of protein was electrophoresed and evaluated via Western immunoblotting and densitometry as described previously. 7, 8 Antibodies raised against rat transferrin (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), haptoglobin (Abcam, Cambridge, UK), Bcl-2 (Transduction Laboratories, Inc., Lexington, KY, USA), CuZn SOD (Stress Marq Biosciences Inc., Victoria, Canada), catalase (Chemicon International Inc., Temecular, CA, USA), and b-actin (SigmaAldrich) were used. Proteins on sodium dodecyl sulfatepolyacrylamide gel electrophoresis gels were transferred to nitrocellulose filters and stained as described previously. 7, 8 The density of the band with the appropriate molecular mass was determined semiquantitatively via densitometry by using an image-analyzing system (Alpha Innotech, San Leandro, CA).
Liver histology assessment
The right liver lobe was cut and fixed in 4% buffered neutral formalin at 4 C. Liver specimens were embedded in paraffin and stained with both hematoxylin and eosin. Liver histology was assessed by a single observer blinded to the experimental protocol and biochemical results. The severity of hepatocyte inflammation, as indicated by leukocyte infiltration and fibrosis, was estimated as an indicator of liver damage. Liver fibrosis scores were as follows: 0, no fibrosis; 1, perivenular and/or pericellular fibrosis; 2, septal fibrosis; 3, incomplete cirrhosis; and 4, complete cirrhosis. The tissue slices were blindly scored by two expert pathologists. The degree of fibrosis was expressed as the mean of 10 different fields on each slide.
Statistical analysis
All values were expressed as mean [standard error of the mean (SEM)]. Within-groups differences were evaluated using the paired t test. One-way analysis of variance was used for establishing differences between groups. Intergroup comparisons were made using Duncan's multiplerange test. Differences were regarded as significant if p < 0.05 was attained.
Results
Comparison of the antioxidant activities of GTE, vitamin C, vitamin E, and b-carotene
The scavenging activities of GTE, vitamin C, vitamin E, and b-carotene against O 2 e are shown in Fig. 1Ae1D . All four antioxidants inhibited O 2 e at a dose of 1 mg/mL in a dosedependent manner as follows: GTE (86.3%) > vitamin C (83.1%) > vitamin E (23.1%) > b-carotene (3.4%).
The antioxidant activity against H 2 O 2 is shown in Fig. 2Ae2D . All four antioxidants inhibited H 2 O 2 at a dose of 1 mg/mL in a dose-dependent manner as follows: GTE
7%).
The antioxidant response against HOCl is shown in Fig. 3Ae3D . GTE and vitamin C displayed dose-dependent inhibition of HOCl activity, but b-carotene and vitamin E did not. The inhibition of HOCl activity at 1 mg/mL of each antioxidant was in the following order: GTE (97.5%) > vitamin C (95.3%) > vitamin E (71.1%) > b-carotene (12.2%). According to the above findings, GTE is the most efficient antioxidant scavenging O 2 e.
, H 2 O 2 , and HOCl.
CCl 4 increased bile and blood ROS production and plasma ALT and hepatic hydroxyproline levels
In comparison to the levels in controls, the biliary O 2 e (lucigenin counts; Fig. 4A ) and H 2 O 2 (luminol counts; Fig. 4B ) and the blood O 2 e (lucigenin counts, Fig. 4C ) and H 2 O 2 (luminol counts; Fig. 4D ) levels were consistently and significantly elevated after 8 weeks of CCl 4 injury. The increased levels of bile and blood ROS were significantly reduced by treatment with both low and high doses of GTE. We also found that CCl 4 produced a significant increase in plasma ALT (Fig. 4E ) and aspartate aminotransferase (Fig. 4F ) levels, as well as a significant decrease in plasma albumin level (Fig. 4G) . CCl 4 increased the hepatic hydroxyproline content (Fig. 4H) . CCl 4 plus both low and high doses of GTE showed a significant decrease in enzyme levels and a significant increase in albumin levels. GTE did not show dose-dependent effects in this study.
Influence of CCl 4 and GTE on morphology and bile proteomics
Marked lipid accumulation, fibrosis, necrosis, and leukocyte infiltration were found in CCl 4 -treated livers (Fig. 5B ) when compared to control livers (Fig. 5A ). Both low (Fig. 5C ) and high doses of GTE (Fig. 5D ) attenuated the morphologic changes. Quantitative data describing the increased leukocyte infiltration (Fig. 5I ) and fibrosis scores (Fig. 5 J) are indicated; both low and high doses of GTE significantly decreased CCl 4 -induced leukocyte infiltration and fibrosis. For proteomic analysis, 5-mL bile samples from control rats (n Z 3), CCl 4 -treated rats (n Z 3), and GTE-treated CCl 4 rats (n Z 3 each, LGT and HGT dose groups) were subjected to 2-DE analysis, and the proteins were visualized with silver staining. Fig. 5Ee5 G illustrate the representative silver-stained 2-DE gels of the control, CCl 4 , and CCl 4 plus LGT treatment. The six identified major proteins included transferrin (spot 1), polymeric immunoglobin A receptor (spot 2), acute-phase a-1 protein (spot 3), kallikrein-binding protein (spot 4), haptoglobin (spot 5), and IgA a-chain (spot 6). After 8 weeks of CCl 4 injury, the expression of these six biliary proteins was upregulated. Enzyme-linked immunosorbent assay analysis confirmed the increased biliary transferrin (Fig. 5 K) and haptoglobin (Fig. 5L) levels. GTE supplementation decreased the CCl 4 -enhanced acute-phase protein secretion. Western blot (Fig. 5H ) and statistical analysis showed that CCl 4 markedly increased biliary transferrin (Fig. 5 K) and haptoglobin (Fig. 5L ) levels and decreased hepatic Bcl-2 (Fig. 5O) , catalase (Fig. 5P) , and CuZn SOD (Fig. 5Q) protein expression. Both low and high doses of GTE reduced acute-phase protein expression and preserved antioxidant and antiapoptotic protein expression after CCl 4 injury.
Discussion
A previous study has described plant flavonoids with hepatoprotective qualities, which were primarily attributed to their ability to scavenge O 2 e.
, H 2 O 2 , HO
, and HOCl production from rat liver microsomes. 20 Our study compared the antioxidant capabilities of GTE, vitamin C, vitamin E, and bcarotene against O 2 e. , H 2 O 2 , and HOCl activity. The antioxidant capability of 1 mg of each antioxidant against O 2 e. , H 2 O 2 , and HOCl was in the following order: GTE > vitamin C > vitamin E > b-carotene. These in vitro data further confirmed previous findings that GTE is more efficient than vitamins C and E in palliating hemodialysis-induced plasma H 2 O 2 and HOCl activities, lipid peroxidate (phosphatidylcholine hydroperoxide) production, and C-reactive protein and proinflammatory cytokine expression in end-stage renal disease patients. 12, 13 According to our findings, GTE is the most efficient antioxidant to scavenge O 2 e. , H 2 O 2 , and HOCl, and it may have therapeutic potential in CCl 4 -induced oxidative stress.
In this study, we applied a well-established enhanced chemiluminescence method to measure the generation of various types of ROS. 7, 8, 12, 13 This method has been successfully adapted to measure the amounts of ROS in cultured cells, bile, whole blood, and urinary bladder, liver, and kidney cells. Our evidence indicated that the enhanced levels of O 2 e. , H 2 O 2 , and HOCl in vitro and the bile and blood O 2 e and H 2 O 2 levels after CCl 4 injury were significantly depressed by GTE.
The causes of hepatic injury include alcoholism, intoxication, viral infection, and immunodeficiency. CCl 4 chemical-induced hepatic damage is a popular model used to investigate the chemopreventive function of phytochemicals or nutraceuticals. After the metabolism of CCl 4 , a large amount of ROS is produced. In this study, during the 8 weeks of CCl 4 injury, the expressions of Bcl-2, CuZn SOD, and catalase protein were significantly lower than those in the controls (Fig. 5H) . CCl 4 increases the oxidant/antioxidant ratios in the liver. According to the free radical theory, modulation of this phenomenon is one of the possible strategies to inhibit or mitigate the damage induced by toxic radicals. Therefore, we evaluated the antioxidant and hepatoprotective efficacy of GTE. Intake of antioxidants like vitamin E could increase the antioxidant capacity in serum and attenuate CCl 4 -induced liver injury. 21 In our study, the antioxidant defense mechanism of Bcl-2, CuZn SOD, and catalase was markedly preserved, even enhanced, after 8 weeks of GTE supplementation in the CCl 4 -treated livers. Our data suggested that GTE, via catechins, not only directly exhibited its anti-inflammatory and antioxidant characteristics as described earlier, but also modulated the physiological environment, especially by inhibiting oxidative damage and upregulating antioxidant and antiapoptotic status.
In our previous study, the GTE dose showed no significant effect on ROS level, biochemical parameters, and inflammation. 9 The ingestion of GTE increased the plasma concentration of several catechins. According to our previous report, the concentrations of rat plasma epigallocatechin gallate (10.1 AE 0.3 or 13.2 AE 1.2 ng/mL), epicatechin gallate (5.1 AE 0.6 or 6.3 AE 0.9 ng/mL), and gallocatechin gallate (4.9 AE 0.7 or 5.7 AE 0.8 ng/mL) were similar between the low and high GTE dose groups. 9 We suggest that GTE doses of 4 and 25 mg/kg body weight may have a similar influence on the reduction of CCl 4 -induced liver injury.
In response to various types of oxidative stress and toxicity, several acute-phase proteins are synthesized and released from the damaged liver.
22e28 In our bile proteomics analysis, we have identified six acute phase proteins, 8 which regulate intracellular trafficking in the hepatocytes via endosomal transcytotic and lysosomal function. These acute phase proteins, like polymeric IgA receptor and transferrin, are upregulated, whereas haptoglobin is depressed in acute liver injury. 8 According to the present data, CCl 4 toxicity increases the levels of transferrin, polymeric IgA receptor, major acute-phase a-1 protein precursor, kallikrein binding protein, and haptoglobin as measured via 2D-PAGE proteomics, suggesting a disruption of intracellular trafficking integrity in the hepatocytes after CCl 4 -induced toxicity. In addition, CCl 4 enhances the expression of biliary haptoglobin, which is an inflammationinducible plasma protein. 28 After long-term high and lowdose GTE supplementation, the enhanced expression of these proteins is greatly diminished. We suggest that GTE can protect against CCl 4 -induced injury by attenuating several upregulated acute phase proteins.
In addition to exacerbating oxidative stress, CCl 4 triggers apoptosis, inflammation, and increased collagen gene and protein expression, subsequently leading to liver fibrosis and cirrhosis. 1 Furthermore, CCl 4 causes necrosis, mononuclear cell infiltration, steatosis, foamy degeneration of hepatocytes, and cirrhosis. 29 Our histopathologic observations in livers subjected to CCl 4 injury (Fig. 5 ) are in agreement with the findings of previous studies. 1, 29 Secondary liver injury occurs from inflammatory processes initiated by the activation of Kupffer cells, which release chemoattractants and neutrophil activators. 30 Kupffer cell activation increases ROS amounts and plays a critical role in hepatocellular injury. 7, 8 The enhanced ROS can further activate hepatic stellate cells, a process characterized by the enhanced production of extracellular matrix and accelerated proliferation. Because hepatocellular apoptosis, hepatic inflammation, and fibrosis are prominent characteristics in chronic liver diseases, Liu et al 1 found that the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling and CD68-double-positive apoptotic Kupffer cells located in the portal or fibrotic septa area were situated close to hepatic stellate cells. Thus, antioxidant activity and the inhibition of free radical generation are important in protecting the liver from CCl 4 -induced damage. 31 The antioxidants may inhibit Kupffer cell activation and may secondarily depress hepatic stellate cell activation and collagen accumulation. However, further studies will be required to validate this hypothesis.
Both low and high doses of GTE significantly reduced plasma ALT levels and hepatic hydroxyproline content in CCl 4 -treated rats. We also found that CCl 4 -induced pathologic changes in lipid accumulation, leukocyte infiltration, and fibrosis were ameliorated by GTE supplementation. This beneficial effect may be due to GTE's antioxidant, antiapoptotic, anti-inflammatory, and antifibrogenic effects.
In contrast to GTE's beneficial potential, another report has indicated the hepatotoxic effects of high oral doses of EGCG (750 or 1500 mg/kg) in mice. 32 These doses increased plasma ALT levels and produced moderate to severe hepatic necrosis associated with oxidative stress, including increased levels of hepatic lipid peroxidation, plasma 8-isoprostane, interleukin-6, monocyte chemoattractant protein-1, and hepatic metallothionein protein. However, the dosages we used (4 and 20 mg/kg) were significantly lower. Overdose of EGCG or GTE should be avoided due to this hepatotoxicity.
In conclusion, GTE supplementation attenuates CCl 4 -enhanced hepatic oxidative stress, fibrosis, acute phase protein excretion, and hepatic dysfunction via the antioxidant, anti-inflammatory, and antiapoptotic defense mechanisms.
